Methods Of Treating Fabry Patients Having Renal Impairment

Patent No. EP4062916 (titled "Methods Of Treating Fabry Patients Having Renal Impairment") was filed by Amicus Therapeutics on May 30, 2018. The application was issued on Oct 9, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BRAND MURRAY FULLERJul 9, 2025BRAND MURRAY FULLER
TEVA PHARMACEUTICALSJul 9, 2025D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4062916

AMICUS THERAPEUTICS
Application Number
EP22165669A
Filing Date
May 30, 2018
Status
Granted And Under Opposition
Sep 6, 2024
Publication Date
Oct 9, 2024